VIRTUAL REGISTRATION: 3rd Annual Conference on Psychedelics and Psychedelic Medicine

November 3, 2023 to November 4, 2023

We invite you to join us Virtually for our 3rd Annual Conference on Psychedelics and Psychedelic Medicine!


Please Note: The conference will be held in Easter Daylight Time (EDT)

This conference will provide up-to-date overviews and discussions of advances in the field of psychedelics and psychedelic-assisted therapies, with an emphasis on clinical studies and practice. Mechanisms of action including pharmacology, neuroscience, psychodynamic theory will be discussed, with a focus on specific clinical entities such as depression, PTSD, and addictions. Additional panel discussions and presentations will explore history, ethics, cultural issues, plant medicine, and many other relevant topics within the rapidly growing field of psychedelic medicine.

You will receive an email communication (to the email registered to your MGH Psychiatry Academy account) as we get closer to the conference date with details on the zoom instructions and attending virtually.


MDs/Doctoral-Level Professionals

Super Early Bird Registration (on or before July 1, 2023): $650.00
Early Bird Registration (on or before August 15, 2023): $700.00
Regular Registration (after August 15, 2023): $750.00

Other Professionals or Trainees

Super Early Bird Registration (on or before July 1, 2023): $585.00
Early Bird Registration (on or before August 15, 2023) $630.00
Regular Registration (after August 15, 2023) $675.00

Residents & Medical Students: $150.00

***The deeply discounted Super Early Bird Registration rate is NON-REFUNDABLE and NON-TRANSFERABLE and will not be refunded under any circumstances.

Live Registration: 

The conference occurs live at the Westin Copley Place in Boston. For more information about in-person attendance and the venue, please visit our live registration page: 

3rd Annual Psychedelics Conference: Live Registration - Click Here


We provide all attendees  with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference. 

Cancellation Policy

A refund minus a $100.00 administrative fee will be issued for refund requests received by October 2, 2023.  No refunds will be issued for refund requests made after October 2, 2023. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.

Target Audience

This program is intended for mental health practitioners including psychiatrists, psychiatric nurse practitioners, social workers and clinical psychologists.

Learning Objectives

By the end of this program, participants will be able to:

  1. Compare different models of psychedelic-assisted psychotherapy (eg, psycholytic vs psychedelic)
  2. Explain the neuropsychopharmacology of classical psychedelics as well as atypical psychedelics such as ketamine and empathogens such as MDMA
  3. Identify hypotheses for mechanisms of action of psychedelics on the brain, based on recent neuroimaging studies
  4. Critique contemporary medico-cultural issues within psychedelic research, including race-based structural biases and epistemic injustice
  5. Assess potential applications of psychedelic-assisted therapy in extra-psychiatric fields, such as within palliative care and spirituality, as well as within medicine, such as for pain and immunomodulation
Course summary
Registration opens: 
Course closes: 
Event starts: 
11/03/2023 - 8:00am EDT
Event ends: 
11/04/2023 - 5:00pm EDT



Program Agenda coming soon! 

Course Director

Franklin King, MD


Full Faculty List Coming Soon! 



Accreditation Information is under review. Please check back for available CME! 


Please login or register to take this course.


David H. Rubin, MD, reviewer
Jane Pimental, MPH
Susan E. Sprich, PhD, psychologist reviewer
Franklin King, MD

Disclosure Information

In accord with the disclosure policy of McLean Hospital as well as guidelines set forth by the Accreditation Council on Continuing Medical Education, all people in control of educational content, including speakers, course directors, planners, and reviewers, have been asked to disclose all relevant financial relationships with commercial interests of both themselves and their spouses/partners over the past 12 months, as defined below:                            

Ineligible Companies

The ACCME defines an "Ineligible company" as "those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients." For more information, visit

Financial relationships 

Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.  

Mitigation of Financial Relationships 

All financial relationships are reviewed to determine which ones are relevant, and then measures are taken to mitigate all relevant financial relationships and ensure that they do not insert commercial bias into the content of the education. 

The following planners, speakers, content reviewers, and others in control of educational content have reported financial relationships with ineligible companies over the past 24 months. Measures have been taken to mitigate the impact of these financial relationships on the educational content and ensure that they do not insert commercial bias into the content of this education

Susan Sprich, PhD (Psychologist Reviewer)
Royalties (Co-Author): Oxford University Press
Royalties (Co-Edited Book): Springer
Honoraria (Associate Editors): Association for Behavioral and Cognitive Therapies (ABCT)

All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have, on behalf of themselves and their spouse or partner, reported no financial relationships related to the content of this activity.

Hardware/Software Specifications

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration

Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher

Minimum Requirements

Windows PC:500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit